US 11,752,254 B2
Radioisotope delivery system with multiple detectors to detect gamma and beta emissions
Clif Moyers, Oak Ridge, TN (US); Adrian Nunn, Lambertville, NJ (US); Andrew Schimmoeller, Plain City, OH (US); and Brian Cherundolo, White Marsh, MD (US)
Assigned to Bracco Diagnostics Inc., Monroe Township, NJ (US)
Appl. No. 16/334,882
Filed by BRACCO DIAGNOSTICS INC., Monroe Township, NJ (US)
PCT Filed Sep. 20, 2017, PCT No. PCT/US2017/052535
§ 371(c)(1), (2) Date Mar. 20, 2019,
PCT Pub. No. WO2018/057634, PCT Pub. Date Mar. 29, 2018.
Claims priority of provisional application 62/397,026, filed on Sep. 20, 2016.
Claims priority of provisional application 62/397,025, filed on Sep. 20, 2016.
Claims priority of provisional application 62/397,022, filed on Sep. 20, 2016.
Prior Publication US 2020/0030522 A1, Jan. 30, 2020
Int. Cl. A61M 5/00 (2006.01); G21G 4/08 (2006.01); A61N 5/10 (2006.01); A61M 5/142 (2006.01); G01T 1/16 (2006.01); A61K 51/12 (2006.01); G21F 5/015 (2006.01); G21G 1/00 (2006.01); A61M 5/14 (2006.01); A61M 5/162 (2006.01); A61M 5/168 (2006.01); G01T 1/20 (2006.01); G21H 5/02 (2006.01); G01T 7/00 (2006.01)
CPC A61M 5/007 (2013.01) [A61K 51/121 (2013.01); A61K 51/1282 (2013.01); A61M 5/142 (2013.01); A61M 5/1408 (2013.01); A61M 5/162 (2013.01); A61M 5/16827 (2013.01); A61M 5/16881 (2013.01); A61N 5/1007 (2013.01); G01T 1/20 (2013.01); G01T 7/005 (2013.01); G21F 5/015 (2013.01); G21G 1/0005 (2013.01); G21G 4/08 (2013.01); G21H 5/02 (2013.01); A61K 2123/00 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3313 (2013.01); A61M 2205/3389 (2013.01); A61M 2205/702 (2013.01); A61N 2005/1021 (2013.01); G01T 1/1603 (2013.01); G21G 2001/0031 (2013.01)] 22 Claims
OG exemplary drawing
 
1. An infusion system comprising:
a frame that carries a beta detector, a gamma detector, an eluate-receiving container, and a waste container and is further configured to receive a radioisotope generator that generates radioactive eluate via elution,
wherein the beta detector is positioned to measure beta emissions emitted from the radioactive eluate, and
the gamma detector is positioned to measure gamma emissions emitted from a portion of the radioactive eluate received in the eluate receiving container to evaluate a safety of the radioactive eluate delivered by the infusion system to ensure that the radioactive eluate generated by the radioisotope generator is safe for patient infusion.